H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 35 900 KRW -1.78%
Market Cap: 1T KRW
Have any thoughts about
HK Inno.N Corp?
Write Note

HK Inno.N Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HK Inno.N Corp
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
H
HK Inno.N Corp
KOSDAQ:195940
Capital Expenditures
-â‚©39.1B
CAGR 3-Years
26%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Capital Expenditures
-â‚©153.3B
CAGR 3-Years
-14%
CAGR 5-Years
-26%
CAGR 10-Years
-15%
SK Biopharmaceuticals Co Ltd
KRX:326030
Capital Expenditures
-â‚©3.2B
CAGR 3-Years
39%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Capital Expenditures
-â‚©56.8B
CAGR 3-Years
-12%
CAGR 5-Years
23%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Capital Expenditures
-â‚©31.6B
CAGR 3-Years
-22%
CAGR 5-Years
-27%
CAGR 10-Years
-13%
C
Celltrion Pharm Inc
KOSDAQ:068760
Capital Expenditures
-â‚©5.6B
CAGR 3-Years
30%
CAGR 5-Years
26%
CAGR 10-Years
16%
No Stocks Found

HK Inno.N Corp
Glance View

Market Cap
1T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
70 395.87 KRW
Undervaluation 49%
Intrinsic Value
Price
H

See Also

What is HK Inno.N Corp's Capital Expenditures?
Capital Expenditures
-39.1B KRW

Based on the financial report for Dec 31, 2023, HK Inno.N Corp's Capital Expenditures amounts to -39.1B KRW.

What is HK Inno.N Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-23%

Over the last year, the Capital Expenditures growth was -71%. The average annual Capital Expenditures growth rates for HK Inno.N Corp have been 26% over the past three years , -23% over the past five years .

Back to Top